Precision BioSciences begins dosing in Phase 1/2 FUNCTION-DMD study
Precision BioSciences says it has commenced dosing in its Phase 1/2 FUNCTION-DMD study.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Precision BioSciences says it has commenced dosing in its Phase 1/2 FUNCTION-DMD study.